These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6675811)

  • 21. Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosis.
    Whitaker JN; Williams PH; Layton BA; McFarland HF; Stone LA; Smith ME; Kachelhofer RD; Bradley EL; Burgard S; Zhao G
    Ann Neurol; 1994 May; 35(5):577-85. PubMed ID: 7513981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radioimmunologic determination of myelin basic proteins in cerebral spinal fluid in central nervous system disorders].
    Bürgisser P; Matthieu JM; Gautier E
    Rev Med Suisse Romande; 1982 May; 102(5):535-6. PubMed ID: 6182594
    [No Abstract]   [Full Text] [Related]  

  • 23. T cell receptor V beta gene usage in the recognition of myelin basic protein by cerebrospinal fluid- and blood-derived T cells from patients with multiple sclerosis.
    Chou YK; Buenafe AC; Dedrick R; Morrison WJ; Bourdette DN; Whitham R; Atherton J; Lane J; Spoor E; Hashim GA
    J Neurosci Res; 1994 Feb; 37(2):169-81. PubMed ID: 7512148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous system.
    Mehling M; Kuhle J; Regeniter A
    Neurologist; 2008 Jan; 14(1):60-5. PubMed ID: 18195662
    [No Abstract]   [Full Text] [Related]  

  • 25. Determination of cyclophosphamide in urine, serum and cerebrospinal fluid of multiple sclerosis patients by field desorption mass spectrometry.
    Bahr U; Schulten HR; Hommes OR; Aerts F
    Clin Chim Acta; 1980 Apr; 103(2):183-92. PubMed ID: 7371197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The visual system in myelin disorders. Vascular and other factors.
    Feigin I
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():121-3. PubMed ID: 6675800
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cytoimmunological profile of cerebrospinal fluid in diagnosis of multiple sclerosis].
    Caudie C; Birouk AM; Bancel J; Claudy D; Gignoux L; Vukusic S; Confavreux C
    Pathol Biol (Paris); 2005 Mar; 53(2):68-74. PubMed ID: 15708649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytology of the cerebrospinal fluid].
    Dietrichson P
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2121. PubMed ID: 4773987
    [No Abstract]   [Full Text] [Related]  

  • 29. [A study of soluble form of L-selectin in blood of patients with neuroimmunological disorders].
    Sakai T; Inoue A; Koh CS; Yamazaki M; Yanagisawa N
    Arerugi; 1996 Jul; 45(7):672-7. PubMed ID: 8831172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis.
    Bagnato F; Durastanti V; Finamore L; Volante G; Millefiorini E
    Neurol Sci; 2003 Dec; 24 Suppl 5():S301-4. PubMed ID: 14652795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of examination of the oligoclonal bands in cerebrospinal fluid in multiple sclerosis and other neurological disorders].
    Ai KZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Oct; 16(5):285-8. PubMed ID: 6675952
    [No Abstract]   [Full Text] [Related]  

  • 32. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis.
    Mahovic D; Petravic D; Petelin Z; Zurak N; Horvat G; Hajnsek S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):230-2. PubMed ID: 15177773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Essential fatty acids in serum and cerebrospinal fluid of patients with multiple sclerosis].
    Seidel D
    Nervenarzt; 1981 Aug; 52(8):489-90. PubMed ID: 7279082
    [No Abstract]   [Full Text] [Related]  

  • 35. [Changes of lipids and their fractions in serum and cerebrospinal fluid in disseminated cerebrospinal sclerosis].
    Vymazal J
    Cas Lek Cesk; 1968; 107(45):1352-5. PubMed ID: 4879449
    [No Abstract]   [Full Text] [Related]  

  • 36. [Serum and liquor immunoelectrophoresis in normal subjects and in patients affected by degenerative and spondylosic myelopathies].
    Rizzo PA; Bernardi G; Amabile G
    Riv Neurobiol; 1967; ():Suppl:1103+. PubMed ID: 5616973
    [No Abstract]   [Full Text] [Related]  

  • 37. CD4 T cell activation and disease activity at onset of multiple sclerosis.
    Jensen J; Langkilde AR; Fenst C; Nicolaisen MS; Roed HG; Christiansen M; Sellebjerg F
    J Neuroimmunol; 2004 Apr; 149(1-2):202-9. PubMed ID: 15020081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sclerosis with uncommon cerebrospinal fluid findings.
    Rot U; Mesec A; Pogacnik T
    Croat Med J; 2003 Dec; 44(6):697-701. PubMed ID: 14652881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic demyelinating polyneuropathy associated with multiple sclerosis: a patient with two diseases].
    Quesada MA; Izquierdo G; Bautista J; Chinchón I
    Rev Neurol; 1995; 23(123):1053-5. PubMed ID: 8556591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum and cerebrospinal fluid C2 in multiple sclerosis.
    Delasnerie-Laupretre N; Prevot D; Martin-Mondiere C; Eizenbaum JF; Degos JD; Sobel AT
    J Clin Lab Immunol; 1981 Jul; 6(1):23-5. PubMed ID: 7265172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.